The assessment of combined first trimester screening in women of advanced maternal age in an Asian cohort

Singapore Medical Journal

Volumn 56, Issue 1, 2015, Pages 47-52

  Li, Sarah Weiling ^a   Barrett, Angela Natalie ^b   Gole, Leena ^a   Tan, Wei Ching ^c   Biswas, Arijit ^a   Tan, Hak Koon ^c   Choolani, Mahesh ^b  

^a NATIONAL UNIVERSITY HOSPITAL   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c SINGAPORE GENERAL HOSPITAL   (Singapore)

Author keywords

Cell free fetal DNA; Down syndrome; First trimester screening; Noninvasive prenatal testing

Indexed keywords

ADOLESCENT; ADULT; AMNIOCENTESIS; ANEUPLOIDY; ARTICLE; ASIAN; CHORION VILLUS SAMPLING; CHROMOSOME ABERRATION; CHROMOSOME TRANSLOCATION; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; DIGEORGE SYNDROME; ETHNICITY; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; FEMALE; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; HEALTH CARE COST; HEALTH CENTER; HUMAN; KARYOTYPING; LIVE BIRTH; MAJOR CLINICAL STUDY; MATERNAL AGE; MEDICAL ASSESSMENT; MEDICAL RECORD; PREDICTIVE VALUE; PREGNANCY OUTCOME; PRENATAL SCREENING; SCREENING TEST; SENSITIVITY AND SPECIFICITY; SPONTANEOUS ABORTION; TRISOMY 13; TRISOMY 18; TRISOMY 21; TURNER SYNDROME; ULTRASOUND; ASIA; COHORT ANALYSIS; DOWN SYNDROME; MATERNAL SERUM SCREENING TEST; MIDDLE AGED; PREGNANCY; PRENATAL DIAGNOSIS; PROCEDURES; RISK FACTOR; SINGAPORE; TRISOMY;

DNA;

ADOLESCENT; ADULT; ANEUPLOIDY; ASIA; COHORT STUDIES; DNA; DOWN SYNDROME; FEMALE; HUMANS; KARYOTYPING; MATERNAL AGE; MATERNAL SERUM SCREENING TESTS; MIDDLE AGED; PREGNANCY; PREGNANCY OUTCOME; PREGNANCY TRIMESTER, FIRST; PRENATAL DIAGNOSIS; RISK FACTORS; SINGAPORE; TRISOMY;

EID: 84921720888     PISSN: 00375675     EISSN: None     Source Type: Journal    
DOI: 10.11622/smedj.2015009     Document Type: Article

References (27)

1. Wapner R, Thom E, Simpson JL, et al; First Trimester Maternal Serum Biochemistry and Fetal Nuchal Translucency Screening (BUN) Study Group. First-trimester screening for trisomies 21 and 18. N Engl J Med 2003; 349:1405-13.
2. Malone FD, Canick JA, Ball RH, et al; First- and Second-Trimester Evaluation of Risk (FASTER) Research Consortium. First-trimester or second-trimester screening, or both, for Down's syndrome. N Engl J Med 2005; 353:2001-11.
3. Kagan KO, Wright D, Baker A, Sahota D, Nicolaides KH. Screening for trisomy 21 by maternal age, fetal nuchal translucency thickness, free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A. Ultrasound Obstet Gynecol 2008; 31:618-24.
4. Avgidou K, Papageorghiou A, Bindra R, Spencer K, Nicolaides KH. Prospective first-trimester screening for trisomy 21 in 30,564 pregnancies. Am J Obstet Gynecol 2005; 192:1761-7.
5. Kagan KO, Etchegaray A, Zhou Y, Wright D, Nicolaides KH. Prospective validation of first-trimester combined screening for trisomy 21. Ultrasound Obstet Gynecol 2009; 34:14-8.
6. Spencer K, Spencer CE, Power M, Dawson C, Nicolaides KH. Screening for chromosomal abnormalities in the first trimester using ultrasound and maternal serum biochemistry in a one-stop clinic: a review of three years prospective experience. BJOG 2003; 110:281-6.
7. Peuhkurinen S, Laitinen P, Ryynanen M, Marttala J. First trimester Down syndrome screening is less effective and the number of invasive procedures is increased in women younger than 35 years of age. J Eval Clin Pract 2013; 19:324-6.
8. Chou CY, Hsieh FJ, Cheong ML, et al. First-trimester Down syndrome screening in women younger than 35 years old and cost-effectiveness analysis in Taiwan population. J Eval Clin Pract 2009; 15:789-96.
9. Bindra R, Heath V, Liao A, Spencer K, Nicolaides KH. One-stop clinic for assessment of risk for trisomy 21 at 11-14 weeks: a prospective study of 15 030 pregnancies. Ultrasound Obstet Gynecol 2002; 20:219-25.
10. Hadlow NC, Hewitt BG, Dickinson JE, Jacoby P, Bower C. Community-based screening for Down's Syndrome in the first trimester using ultrasound and maternal serum biochemistry. BJOG 2005; 112:1561-4.
11. Bianchi DW, Platt LD, Goldberg JD, et al; MatErnal Blood IS Source to Accurately diagnose fetal aneuploidy (MELISSA) Study Group. Genome-wide fetal aneuploidy detection by maternal plasma DNA sequencing. Obstet Gynecol 2012; 119:890-901.
12. Chiu RW, Akolekar R, Zheng YW, et al. Non-invasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing: large scale validity study. BMJ 2011; 342:c7401.
13. Norton ME, Brar H, Weiss J, et al. Non-Invasive Chromosomal Evaluation (NICE) Study: results of a multicenter prospective cohort study for detection of fetal trisomy 21 and trisomy 18. Am J Obstet Gynecol 2012; 207:137. e1-8.
14. Gil MM, Akolekar R, Quezada MS, Bregant B, Nicolaides KH. Analysis of cell-free DNA in maternal blood in screening for aneuploidies: meta-analysis. Fetal Diagn Ther 2014; 35:156-73.
15. Soothill PW. Non-invasive Prenatal Testing for Chromosomal Abnormalities using Maternal Plasma DNA. Scientific Impact Paper No 15. March 2014.
16. Gregg AR, Gross SJ, Best RG, et al. ACMG statement on noninvasive prenatal screening for fetal aneuploidy. Genet Med 2013; 15:395-8.
17. American College of Obstetricians and Gynecologists Committee on Genetics. Committee Opinion No. 545: Noninvasive prenatal testing for fetal aneuploidy. Obstet Gynecol 2012; 120:1532-4.
18. Benn P, Borell A, Chiu R, et al. Position statement from the Aneuploidy Screening Committee on behalf of the Board of the International Society for Prenatal Diagnosis. Prenat Diagn 2013; 33:622-9.
19. Fetal Medicine Foundation guidelines for First Trimester Screening. Available at: http://aogm.org.mo/assets/Uploads/aogm/FMF-files/Guide-for-the-First-Trimester-Screening-program.pdf. Accessed December 15, 2014.
20. Stenhouse EJ, Crossley JA, Aitken DA, et al. First-trimester combined ultrasound and biochemical screening for Down syndrome in routine clinical practice. Prenat Diagn 2004; 24:774-80.
21. Leung TY, Chan LW, Leung TN, et al. First-trimester combined screening for trisomy 21 in a predominantly Chinese population. Ultrasound Obstet Gynecol 2007; 29:14-7.
22. Leung TY, Chan LW, Law LW, et al. First trimester combined screening for Trisomy 21 in Hong Kong: outcome of the first 10,000 cases. J Matern Fetal Neonatal Med 2009; 22:300-4.
23. Yeo GS, Lai FM, Wei X, et al. Validation of first trimester screening for trisomy 21 in Singapore with reference to performance of nasal bone. Fetal Diagn Ther 2012; 32:166-70.
24. Kuppermann M, Nease RF, Learman LA, et al. Procedure-related miscarriages and Down syndrome-affected births: implications for prenatal testing based on women's preferences. Obstet Gynecol 2000; 96:511-6.
25. Tabor A, Vestergaard CH, Lidegaard Ø. Fetal loss rate after chorionic villus sampling and amniocentesis: an 11-year national registry study. Ultrasound Obstet Gynecol 2009; 34:19-24.
26. Leung TY, Spencer K, Leung TN, Fung TY, Lau TK. Higher median levels of free beta-hCG and PAPP-A in the first trimester of pregnancy in a Chinese ethnic group. Implication for first trimester combined screening for Down's syndrome in the Chinese population. Fetal Diagn Ther 2006; 21:140-3.
27. Sahota DS, Leung TY, Fung TY, et al. Medians and correction factors for biochemical and ultrasound markers in Chinese women undergoing first-trimester screening for trisomy 21. Ultrasound Obstet Gynecol 2009; 33:387-93.